摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

nonanediol | 30585-83-2

中文名称
——
中文别名
——
英文名称
nonanediol
英文别名
dioxanon;nonane-1,1-diol
nonanediol化学式
CAS
30585-83-2
化学式
C9H20O2
mdl
——
分子量
160.257
InChiKey
FVXBCDWMKCEPCL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    11
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

文献信息

  • RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION
    申请人:Shibuya Atsushi
    公开号:US20100074083A1
    公开(公告)日:2010-03-25
    Provided are a resin composition comprising 100 parts by mass of the polymer having an alicyclic structure at least in a part of a repeating structural unit and 0.05 to 5 parts by mass of a hindered amine compound having a carbon atom at a ratio of from 67% by weight to 80% by weight in the molecular structure and having a molecular weight of from 500 to 3500, a novel piperidine derivative having a piperidylaminotriazine skeleton, a molded product such as an optical component obtained by molding the resin composition, and an optical pickup device which employs the optical component.
    提供的是一种树脂组合物,包括100质量部分具有环脂环结构的聚合物和0.05至5质量部分的分子结构中至少有部分碳原子的受阻胺化合物,其分子结构中碳原子占比从67%到80%。分子量在500至3500之间,一种具有哌啶基三嗪骨架的新型哌啶生物,以及通过模压树脂组合物获得的光学元件等成型产品,以及采用该光学元件的光学拾取器件。
  • CHIRAL TETRADENTATE LIGAND, METHOD FOR PRODUCING SAME AND TRANSITION METAL COMPLEX OF SAID CHIRAL TETRADENTATE LIGAND
    申请人:TAKASAGO INTERNATIONAL CORPORATION
    公开号:US20200369700A1
    公开(公告)日:2020-11-26
    The present invention relates to a compound represented by the formula (1 A ). G represents a group selected from the group consisting of a monovalent group represented by the formula (G P ) and a monovalent group represented by the formula (G S ). R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 each independently represent a hydrogen atom or a group selected from the group consisting of an alkyl group, an alkenyl group, an aryl group, an aralkyl group, an alkoxy group, a halogeno group, and a halogeno alkyl group.
    本发明涉及一种由式(1A)表示的化合物。G代表从单价基团(GP)表示的基团和从单价基团(GS)表示的基团中选择的基团。R4、R5、R6、R7、R8、R9、R10、R11和R12各自独立地表示氢原子或从烷基、烯基、芳基、芳基烷基、烷氧基、卤素基和卤素烷基组成的基团中选择的基团。
  • [EN] HYDROXYNONYLADENINE ANALOGS WITH ENHANCED LIPOPHILIC AND ANTI-ISCHEMIC TRAITS<br/>[FR] ANALOGUES D'ERYTHRO-HYDROXYNONYLADENINE A PROPRIETES LIPOPHILES ET ANTI-ISCHEMIQUES RENFORCEES
    申请人:CYPROS PHARMACEUTICAL CORPORATION
    公开号:WO1997028803A1
    公开(公告)日:1997-08-14
    (EN) Analogs of erythro-hydroxynonyladenine (EHNA) are disclosed which have been modified by bonding various types of moieties to the #8 or #9 carbon atoms in the 'side chain' portion of the molecule. The compounds inhibit the intracellular enzymatic activity of adenosine deaminase and are therapeutically effective in reducing hypoxic and ischemic damage in heart and brain tissue.(FR) Analogues d'érythro-hydroxynonyladénine (EHNA) qui ont été modifiés par la liaison de divers types de fractions aux atomes de carbone en position 8 ou 9 dans la partie chaîne latérale de la molécule. Ces composés inhibent l'activité enzymatique intracellulaire de l'adénosine désaminase et réduisent efficacement, sur le plan thérapeutique, les lésions ischémiques et hypoxiques des tissus du coeur et du cerveau.
    (中文翻译)披露了已经通过将各种类型的基团连接到分子的“侧链”部分的#8或#9碳原子上而改性的erythro-hydroxynonyladenine(EHNA)的类似物。这些化合物抑制腺苷脱氨酶的细胞内酶活性,并在治疗上有效减少心脏和脑组织的缺氧和缺血损伤。
  • Concentrated, stable, preferably clear, fabric softening composition
    申请人:Trinh Toan
    公开号:US20060058216A1
    公开(公告)日:2006-03-16
    Principal solvents, especially mono-ol and diol principal solvents, having a ClogP of from about 0.15 to about 0.64, preferably from about 0.25 to about 0.62, and more preferably from about 0.40 to about 0.60, are disclosed that have the ability to make clear aqueous fabric softener compositions containing relatively high concentrations of fabric softener actives having ester linkages in their long, hydrophobic chains. The fabric softener actives are either unsaturated, or have intermediate length chains (˜C 12-14 ) and the said principal solvents are used at levels of less than about 40%. Other solvents may be present. Some of the said principal solvents are novel compounds and/or novel mixtures. Premixes of the fabric softening actives, the principal solvents, and, optionally, other solvents are useful in the preparation of complete formulations by obviating/limiting the need for heating.
    本发明揭示了主要溶剂,特别是具有ClogP约为0.15至约0.64,优选为约0.25至约0.62,更优选为约0.40至约0.60的单醇和双醇主要溶剂,具有制备含有长链疏基中酯键的相对高浓度织物柔顺剂活性成分的清澈性织物柔顺剂组合物的能力。织物柔顺剂活性成分可以是不饱和的,也可以具有中等长度的链(约C12-14),所述主要溶剂的使用平小于约40%。其他溶剂可以存在。其中一些主要溶剂是新化合物和/或新混合物。织物柔顺剂活性成分、主要溶剂和可选的其他溶剂的预混物在制备完整配方时是有用的,因为它们可以避免/限制加热的需要。
  • Concentrated, stable fabric softening composition
    申请人:——
    公开号:US20030153483A1
    公开(公告)日:2003-08-14
    Principal solvents, especially mono-ol and diol principal solvents, having a ClogP of from about 0.15 to about 0.64, preferably from about 0.25 to about 0.62, and more preferably from about 0.40 to about 0.60, are disclosed that have the ability to make clear aqueous fabric softener compositions containing relatively high concentrations of fabric softener actives having ester linkages in their long, hydrophobic chains. The fabric softener actives are either unsaturated, or have intermediate length chains (˜C 12-14 ) and the said principal solvents are used at levels of less than about 40%. Other solvents may be present. Some of the said principal solvents are novel compounds and/or novel mixtures. Premixes of the fabric softening actives, the principal solvents, and, optionally, other solvents are useful in the preparation of complete formulations by obviating/limiting the need for heating.
    本发明涉及主要溶剂,特别是具有从约0.15到约0.64的ClogP值的单醇和二醇主要溶剂,优选从约0.25到约0.62,更优选从约0.40到约0.60,具有使含有长的亲性链中的酯键的织物柔软剂活性成分相对高浓度的清澈性织物柔软剂组合物的能力。织物柔软剂活性成分可以是不饱和的,也可以具有中等长度的链(约C12-14),所述主要溶剂的使用平低于约40%。其他溶剂可能也存在。其中一些主要溶剂是新化合物和/或新混合物。织物柔软剂活性成分、主要溶剂和可选的其他溶剂的预混物可用于制备完整配方,从而避免/限制加热的需要。
查看更多